Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Epidemiologic Study to Determine the Prevalence of Neutralizing Antibodies and Related Adaptive Immune Responses to Adeno-Associated Virus (AAV) in Adults With Hemophilia

NCT03185897 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT03185897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03185897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Epidemiologic Study to Determine the Prevalence of Neutralizing Antibodies and Related Adaptive Immune Responses to Adeno-Associated Virus (AAV) in Adults With Hemophilia
Lead sponsor
Baxalta now part of Shire
Phase
Observational
Overall status
Completed
Start date
June 14, 2017
Completion date
March 17, 2021
Enrollment
242 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a, hemophilia b